Disposable blood bags are the biomedical devices used for collection, storage, transportation, and transfusion of blood and its components. In recent times, disposable plastic blood bags has replaced the usage of glass bottles due to problems associated with use of glass bottles including inadequate sterility, leading to blood contamination, and the presence of air bubbles resulted to severe complications during blood transfusion. Disposable plastic blood bags also help in the separation of blood components such as plasma, platelets, and cryoprecipitate, which are used to treat a range of blood disorders.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2170

The global disposable blood bags market size was valued at US$ 230.1 million in 2017, and is expected to witness a CAGR of 12.1% over the forecast period (2018 – 2026).

Increasing Prevalence of Blood Related Disorders such as Blood Cancer, Anemia, Sickle Cell Disease, Hemophilia, and Other Rare Blood Disorders is Expected to Drive the Disposable Blood Bags Market Revenue

Rising prevalence of diseases such as cancer and various blood related disorder (anemia, hemophilia, and sickle cell disease) is increasing demand for blood transfusion, which eventually drives growth of the disposable blood bags market. For instance, according to Red Cross Blood Organization facts of 2017 about blood needs, sickle cell disease affects 90,000 to 100,000 people in the U.S. and approximately 1,000 babies are born with the disease each year. Sickle cell patients often require blood transfusions throughout their lives.

Increasing number of cancer incidences worldwide is also a major factor driving the disposable blood bags market’s growth. For instance, according to American Cancer Society, 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the U.S. by the end of 2018. Majority of these patients will need blood, sometimes daily, during chemotherapy treatment. Furthermore, according to the New York Blood Center, approximately 4.5 million Americans receive blood transfusions each year and 40,000 pints are transfused each day in the country, to save the lives of cancer patients, burn, accident, and trauma victims, mothers delivering babies, newborn babies, transplant patients, surgery patients and others in need.

Market Dynamics

Demand for disposable blood bags are witnessing significant growth owing to rising prevalence of blood related disorders and increasing number of road accidents that require blood transfusion. Blood transfusion is commonly used for supportive care in transplant surgery, cardiovascular surgery, massive trauma, and haematological therapy. According to New York Blood Center (NYBC) 2018 data, car accident and trauma victims may need over 50 red cell transfusions during entire treatment process.

Disposable Blood Bags Market - Competitive Landscape

Key players operating in the global disposable blood bags market include AdvacarePharma, Fresenius Kabi, Grifols, HLL Lifecare, Haemonetics Corporation, Macopharma, Neomedic, Poly Medicure, SURU International, Span Healthcare, and TERUMO PENPOL. Use of biosafety materials in the manufacturing of blood bags and favorable support from government authorities is expected to create huge growth opportunities for disposable blood bag manufacturers.

Browse Complete Report For More Information @ http://bit.ly/31JzvUN

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]